ReviewCureus2024

Long-Term Cardiovascular Outcomes of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Type 2 Diabetes: A Systematic Review.

Salman Tariq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.